阿尔茨海默氏病的阿育吠陀治疗:一个临床案例研究
Mahesh Sharma1, Sourabh Deshmukh2, Trupti Thakre3
1MD Scholar of Kayachikitsa Department; Mahatma Gandhi Ayurved College Hospital and Research Centre, Salod (H), Wardha, Maharashtra, India.
Alternative therapies in health and medicine
|October 7, 2025
概括
这份案例报告表明,阿尔茨海默氏病 (AD) 的阿尔茨海默氏疗法可以帮助减缓认知衰退. 干预措施改善了阿兹海默症患者的记忆,定向和日常功能.
科学领域:
- 神经学 神经学
- 综合医学是一个整体医学.
- 艾尔维达是一种阿育韦德.
背景情况:
- 阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,影响记忆,认知和行为.
- 阿尔茨海默病导致严重的功能衰退,并影响全球数百万人.
- 目前的治疗方法在阻止疾病进展方面有效性有限.
研究的目的:
- 介绍一个关于阿尔茨海默病管理阿尔茨海默病治疗艾尔维达干预疗效的案例研究.
- 探索神经退行性疾病综合治疗方法的潜力.
主要方法:
- 一名55岁的男性患者被诊断患有阿尔茨海默病,他接受了全面的阿育吠陀治疗方案.
- 内部药物包括布拉赫米格里特,金色的萨拉斯瓦塔里什塔,阿什瓦甘达粉和拉索纳克希尔帕卡.
- 施加的潘卡尔玛疗法是纳西亚与潘切伦德里亚尾部,希罗巴斯蒂和阿比扬加与巴拉什瓦甘达尾部.
主要成果:
- 患者在记忆保留和定向方面表现出显著的改善.
- 治疗后观察到情绪稳定和日常功能明显改善.
- 艾尔维达干预措施对认知能力下降和整体幸福感产生了积极影响.
结论:
- 阿尔茨海默病患者的阿育吠陀干预措施在减缓认知衰退和改善日常功能方面表现有前途.
- 这一案例凸显了神经退行性疾病的综合和个性化治疗策略的潜力.
- 需要进一步的研究来验证阿尔茨海默氏病管理中阿尔茨海默氏医学的疗效.
相关概念视频
Alzheimer's Disease: Treatment
822
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
822
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Atherosclerosis IV: Nursing Management
363
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
363
Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Dementia
517
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
517
Chronic Pancreatitis II: Collaborative Care
311
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
311


